News

A 14-gene molecular assay can help identify patients with lung cancer who could benefit from chemotherapy after surgery, according to results of a study presented at the 2025 American Society of ...
The Blood Cancer Discovery Award for Outstanding Journal Article is awarded to the corresponding author of a peer-reviewed, original Research Article or Brief published within the previous two years ...
1Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. *Corresponding Author: M.H. Chui, Department of Pathology and Laboratory Medicine, ...
A single dose of the human papillomavirus vaccine confers protective immunity against infection on par with two doses, according to results from the NCI’s ESCUDDO trial, potentially making it easier ...
From molecules to medicine, from proteomics to prevention, the journals of the AACR cover the entire spectrum of cancer research. Please select the journal that is most appropriate for your manuscript ...
1Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. 2Division of Hematology/Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, Oregon. ...
Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
1Leonard Davis School of Gerontology, University of Southern California, Los Angeles, California. *Corresponding Author: Melanie K. Flores, University of Southern California, 3715 McClintock Avenue, ...
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. Accept ...
Treatment with lurbinectedin (Zepzelca; Jazz Pharmaceuticals) and atezolizumab (Tecentriq; Genentech) improved overall survival (OS) in patients with extensive-stage small cell lung cancer (ES-SCLC) ...
1Department of Biostatistics and Data Science, The University of Texas Health Science Center, Houston, Texas. 2Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, ...
Genentech will collaborate with Orionis Biosciences to discover and develop molecular glues for cancer, the companies announced today. Molecular glues are small molecules that bind to, and promote ...